SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-676742
Filing Date
2016-08-09
Accepted
2016-08-09 16:06:57
Documents
55
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d139085d10q.htm 10-Q 327676
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER d139085dex311.htm EX-31.1 8882
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER d139085dex312.htm EX-31.2 8867
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER d139085dex321.htm EX-32.1 3877
5 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER d139085dex322.htm EX-32.2 3862
  Complete submission text file 0001193125-16-676742.txt   2563535

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cprx-20160630.xml EX-101.INS 444798
7 XBRL TAXONOMY EXTENSION SCHEMA cprx-20160630.xsd EX-101.SCH 37528
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cprx-20160630_cal.xml EX-101.CAL 46704
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cprx-20160630_def.xml EX-101.DEF 109078
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20160630_lab.xml EX-101.LAB 286195
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20160630_pre.xml EX-101.PRE 196294
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33057 | Film No.: 161817924
SIC: 2834 Pharmaceutical Preparations